No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
NRXPW NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM)
- 0.0746
- -0.0001-0.14%
Close Jul 23 16:00 ET
0Market Cap0.00P/E (TTM)
0.0749High0.0746Low10.46KVolume0.0746Open0.0747Pre Close780.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.390052wk High0.00P/B0Float Cap0.039352wk Low--Dividend TTM0Shs Float16.1000Historical High--Div YieldTTM0.40%Amplitude0.0393Historical Low0.0740Avg Price1Lot Size
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
NRx Pharmaceuticals (NASDAQ:NRXP) to Proceed With Two New Drug Applications in 2024; NRX-101 Has Been Returned to the Company for Filing
10-Q: Quarterly report
NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice From Nasdaq That the Company Has Demonstrated Compliance With the Bid Price Requirement
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg